Work

Abstract 1633: Chemical proteomics identifies druggable proteins in ALK-driven neuroblastomas

Year: 2018

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2018-1633

Authors: Smita Matkar, Renata Sano, Colleen Larmour, Kateryna Krytska, Gabriela M. Witek, Mark Gerelus, Tim J. Stuhlmiller, Gary L. Johnson, Yael P. Mosse

Institutions: Children's Hospital of Philadelphia, Spyryx Biosciences (United States), University of North Carolina at Chapel Hill

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2887622849

Cites:

Cited by:

Related to: 10